In a matter of just a few years, “the Cloud” has evolved from a budding new tech feature to one of the main factors driving growth in the technology sector. Cloud computing is now an essential focus for software-related companies, and cloud stocks have piqued the interest of many tech-focused investors.

New technologies and changing consumer behavior have changed the shape of the technology landscape, and an industry that was once centered on the personal computer has adapted to survive in the world of mobile computing and the Cloud. The markets have been paying attention, and some of the best tech stocks have been those that are either primarily cloud-based companies, or those that have shown growth in their cloud operations.

Of course, recent bouts of market-wide volatility have battered these high flyers, but if the bulls can win back momentum heading into the New Year, investors might find that cloud stocks are now available on the cheap.

With this in mind, we’ve highlighted three stocks that are not only showing strong cloud-related activity, but also strong fundamental metrics. Check out these three cloud stocks to buy right now:

1. Veeva Systems Inc. (VEEV Free Report)

Veeva makes cloud-based solutions for the pharmaceutical and life sciences industries. Its main offerings are presented in a software-as-a-service model and delivers industry-specific tools for CRM, content management, and many other enterprise applications. Shares of Veeva currently hold a Zacks Rank #1 (Strong Buy).

VEEV has emerged as a hot growth and momentum stock this year, adding more than 55%—even after recent market-wide pullbacks—amid strong earnings improvements. The firm is projected to finish its current fiscal year with earnings growth of 70% and has a long-term expected growth rate of 19.5%. Veeva is also generating cash flow growth in excess of 86.6% currently.

READ  Letters: Opinion stated as fact - Chico Enterprise-Record

 

2. Attunity Ltd. (ATTU Free Report)

Attunity is a provider of software solutions that enable access, management, sharing, and distribution of data across enterprise platforms and the Cloud. Simply put, Attunity customers have real-time access to a plethora of data and information whenever it’s needed. The firm works closely with trusted cloud leaders like AWS, Cloudera (CLDR), and Microsoft (MSFT).

ATTU is sporting a Zacks Rank #1 (Strong Buy). The reason for this strong rank is a number of recent positive earnings estimate revisions. These bullish revisions have pushed the Zacks Consensus Estimate for ATTU’s current year EPS to 45 cents from 26 cents, while next year’s consensus has moved to 56 cents from 32 cents.

Part of this has to do with Attunity’s most recent quarter, in which the firm delivered earnings of 20 cents per share against estimates of just three cents. Now, current-year growth estimates are calling for revenue and earnings to improve by 35% and 550%, respectively.

 

3. Nice Ltd. (NICE Free Report)

Nice is one of the largest tech companies in Israel, which has quickly become a hotbed for innovation in the industry. The firm makes enterprise software solutions, including cloud solutions, used for customer engagement, compliance, and security purposes. Notably, it offers cloud products that host contact centers, provide analytics, and manage artificial intelligence applications.

NICE sports a Zacks Rank #1 (Strong Buy) and has held up quite nicely during this stretch of selling. The stock is just 6% below its peak and looks poised to make new highs on the back of fresh earnings and revenue growth. Plus, rising earnings estimates have caused significant P/E contraction. On a forward 12-month basis, NICE is trading at just 21.5x earnings, its lowest valuation in over a year.

READ  Could Georgia Tech go bowling in Orlando?

 

3 Medical Stocks to Buy Now

The greatest discovery in this century of biology is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating revenue, and cures for a variety of deadly diseases are in the pipeline.

So are big potential profits for early investors. Zacks has released an updated Special Report that explains this breakthrough and names the best 3 stocks to ride it.

See them today for free >>





READ SOURCE

WHAT YOUR THOUGHTS

Please enter your comment!
Please enter your name here